Correlation between serum DNA methylation and prognosis in gastric cancer patients

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2313-2316

  Ikoma, Hisashi ^a   Ichikawa, Daisuke ^a   Koike, Hiroshi ^a   Ikoma, Daito ^a   Tani, Nobuyuki ^a   Okamoto, Kazuma ^a   Ochiai, Toshiya ^a   Ueda, Yuji ^a   Otsuji, Eigo ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

E cadherin; Gastric cancer; Prognosis; Promoter hypermethylation; Serum assays

Indexed keywords

PROTEIN P16; RETINOIC ACID RECEPTOR BETA; UVOMORULIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GASTRECTOMY; GENETIC CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

CADHERINS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GASTRECTOMY; GENES, P16; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33745545459     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Pisani P, Parkin DM, Bray F et al: Estimate of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 870-873, 1999.
2. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M and Nakayama H: Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8: 86-94, 2005.
3. Nishida S, Kitamura K, Ichikawa D, Koike H, Tani N and Yamagishi H: Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. Anticancer Res 20: 2155-2160, 2000.
4. Ichikawa D, Koike H, Ikoma H et al: Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer. Anticancer Res 24: 2477-2482, 2004.
5. Koike H, Ichikawa D, Ikoma H, Otsuji E, Okamoto K and Yamagishi H: Comparison of methylation-specific polymerase chain reaction with reverse transcriptase-polymerase chain reaction in peripheral blood of gastric cancer patients. J Surg Oncol 87: 182-186, 2004.
6. Koike H, Ichikawa D, Ikoma H et al: Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients. Hepato-gastroenterology 52: 1293-1296, 2005.
7. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma: 2nd English Edition. Gastric Cancer 1: 10-24, 1998.
8. Herman JG, Graff JR, Myohanen S et al: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
9. Machado JC, Oliveira C, Carvalho R et al: E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20: 1525-1528, 2001.
10. Oue N, Motoshita J, Yokozaki H et al: Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 198: 55-59, 2002.
11. Lee TL, Leung WK, Chan MWY et al: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8: 1761-1766, 2002.
12. Graziano F, Arduini F, Ruzzo A et al: Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res 10: 2784-2789, 2004.
13. Leung WK, To KF, Chu ESH et al: Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer 92: 1-5, 2005.
14. Leon SA, Shapiro B, Sklaroff DM and Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650, 1977.
15. Fournie GJ, Courtin JP, Laval F et al: Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 92: 221-227, 1995.
16. Sozzi G, Conte D, Leon M, Cirincione R et al: Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21: 3902-3908, 2004.
17. Lee TL, Leung WK, Chan MW et al: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8: 1716-1766, 2002.
18. Leung WK, To KF, Chu ES et al: Potential diagnostic and prognostic value of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer 82: 1-5, 2005.
19. Soeth E, Vogel I, Roder C et al: Comparative analysis of bone marrrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 67: 3106-3110, 1997.